Francisco Silva, VP of Research and Development at BioRestorative Therapies, Inc. (BRTX), bought 17,374 shares at $0.23 ($4K) on 2019-08-22, disclosed to the SEC on 2019-08-23.
Open-market purchase of $4k BRTX by VP of Research and Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.23 | 8,446 | $2K | 43.7% |
| 2 | $0.28 | 8,928 | $2K | 56.3% |
| Total | $0.26 avg | 17,374 | $4K | 100% |
| Filing → |
| BRTX | BUY | 2023-04-04 | $3K | — | Filing → |
| BRTX | BUY | 2022-11-21 | $2K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $3K | — | Filing → |